Back to Journals » Biologics: Targets and Therapy

Biologics: Targets and Therapy


ISSN: 1177-5491

ISSN: 1177-5475 (Print) - went to online only in 2009

An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.


This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

 

 

 

  

 

 

Latest articles:

- 5 records -

Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis

Alorfi NM, Alourfi MM

Biologics: Targets and Therapy 2022, 16:119-127

Published Date: 5 August 2022

Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population

Santos-Moreno P, Martinez S, Ibata L, Villarreal L, Rodríguez-Florido F, Rivero M, Rojas-Villarraga A, Galarza-Maldonado C

Biologics: Targets and Therapy 2022, 16:107-117

Published Date: 13 July 2022

Successful Treatment of an Adult with Atopic Dermatitis and Lamellar Ichthyosis Using Dupilumab

Binkhonain FK, Aldokhayel S, BinJadeed H, Madani A

Biologics: Targets and Therapy 2022, 16:85-88

Published Date: 23 June 2022

Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician

Saleh A, Ansari U, Abughazaleh S, Glassner K, Abraham BP

Biologics: Targets and Therapy 2022, 16:67-83

Published Date: 17 June 2022


Read more articles